StageZero Life Sciences Company Description

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood.

The company’s lead product is Aristotle, a mRNA-based multi-cancer detection panel that tests blood for multiple discrete cancer.

It also offers ColonSentry, a blood-based test to determine an individual’s current risk for having colorectal cancer.

The company is based in Richmond Hill, Canada.

StageZero Life Sciences Ltd.

Country	Canada
Industry	Diagnostics & Research
Sector	Healthcare
Employees	40
CEO	James Howard-Tripp

Contact Details

Address: 70 East Beaver Creek Road Richmond Hill, ON L4B 3B2 Canada
Website	stagezerolifesciences.com

Stock Details

Ticker Symbol	SZLSF
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	CA8525403017
SIC Code	8011

Key Executives

Name	Position
James R. Howard-Tripp	Executive Chairman and Chief Executive Officer
Dr. Choong-Chin Liew Ph.D.	Co-Founder
Warren Whitehead C.M.A., CPA	Chief Accountant